Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NHS growth a fillip for medtech activity?:

This article was originally published in Clinica

Executive Summary

The UK's National Health Service reports a 3.7% increase in radiology consultants in England and Wales in the year to September 2002, according to a census published today (June 27 2003). The increase may go some way to remedying the "severe" staffing shortages that the Society of Radiographers claims are largely responsible for the low throughput in imaging services (see Clinica No 1061, p 7). Citing an overall 5% annual increase in NHS staffing levels, the government claims that "the NHS is the fastest growing health system in Europe". There are, however, large variations: the number of clinical oncology consultants actually fell by 5.4%. At the other end of the scale, the number of paediatric cardiology consultants increased 120%. Gastroenterology recorded an increase of around 18%, while anaesthetists and obstetrics & gynaecology specialists were up 7%.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062749

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel